Study of prevalence and costs of OUD

Last month Avalere Health released a report totaling the costs of opioid use disorder (OUD) and the impact of treatment in limiting those costs. The study, supported by Indivior, found that the average case of OUD costs $695,000 a year, most of which goes to the criminal justice system. Treatment, however, lowers those costs. The study focuses on the benefits of long‐acting injectable buprenorphine, made by Indivior, which was found to be more cost‐effective than sublingual buprenorphine or methadone.